Neurocrine Biosciences, Inc.NBIXNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$557.20M
↑ 238% above average
Average (9y)
$164.98M
Historical baseline
Range
High:$557.20M
Low:$-110.29M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $557.20M | +54.1% |
| 2023 | $361.60M | +12.0% |
| 2022 | $322.90M | +38.5% |
| 2021 | $233.10M | +7.1% |
| 2020 | $217.60M | +64.5% |
| 2019 | $132.30M | +72.7% |
| 2018 | $76.60M | +175.6% |
| 2017 | $-101.27M | +8.2% |
| 2016 | $-110.29M | -176.2% |
| 2015 | $-39.93M | - |